23 12, 2016 Luca Reggiani Bonetti et al., Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer Diatech Pharmacogenetics2017-11-02T13:28:53+01:00 Leggi di più
13 12, 2016 Chiara Cremolini et al., Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. European Journal of Cancer Diatech Pharmacogenetics2017-08-03T17:23:46+02:00 Leggi di più
8 12, 2016 Beth O. Van Emburgh et al., Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications Diatech Pharmacogenetics2017-08-03T17:32:43+02:00 Leggi di più
27 11, 2016 Adriana Romiti et al., The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs Diatech Pharmacogenetics2017-08-07T10:02:57+02:00 Leggi di più
25 11, 2016 Laura Capelli et al., No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Scientific Reports Diatech Pharmacogenetics2017-08-08T12:52:59+02:00 Leggi di più
12 11, 2016 Greta Alì et al., Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma. Oncology Letters Diatech Pharmacogenetics2017-08-07T10:18:01+02:00 Leggi di più
12 11, 2016 Caterina Marchiò et al., Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept. Neuro-Oncology Diatech Pharmacogenetics2017-08-07T08:59:51+02:00 Leggi di più
8 11, 2016 Federico Pessina et al., Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. Journal of Neuro-Oncology Diatech Pharmacogenetics2017-08-07T10:07:10+02:00 Leggi di più
8 11, 2016 Harriet Johansson et al., Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Research Diatech Pharmacogenetics2017-08-08T12:52:01+02:00 Leggi di più
26 10, 2016 Annemarie Boleij et al., RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres. BMC Cancer Diatech Pharmacogenetics2017-08-08T12:50:48+02:00 Leggi di più
